img

Global Binge Eating Disorder Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Binge Eating Disorder Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase risk. Signs and symptoms include eating unusually large amounts of food, frequently eating alone, feeling that eating behavior is out of control and experiencing depression and anxiety. Treatment includes psychOthersapy, medications and behavioral weight-loss programs.
Binge Eating Disorder Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Binge Eating Disorder Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Retail Pharmacies and Hospital Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Binge Eating Disorder Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Binge Eating Disorder Drug key manufacturers include Roche, Chronos Therapeutics, Heptares, Novo Nordisk, Omeros Corp, Sunovion Pharmaceuticals and Opiant Pharmaceuticals, etc. Roche, Chronos Therapeutics, Heptares are top 3 players and held % sales share in total in 2022.
Binge Eating Disorder Drug can be divided into Antidepressants, Anticonvulsants and Anti-obesity Medications,, etc. Antidepressants is the mainstream product in the market, accounting for % sales share globally in 2022.
Binge Eating Disorder Drug is widely used in various fields, such as Retail Pharmacies, Hospital Pharmacies and Online Pharmacies,, etc. Retail Pharmacies provides greatest supports to the Binge Eating Disorder Drug industry development. In 2022, global % sales of Binge Eating Disorder Drug went into Retail Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Binge Eating Disorder Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Roche
Chronos Therapeutics
Heptares
Novo Nordisk
Omeros Corp
Sunovion Pharmaceuticals
Opiant Pharmaceuticals
Segment by Type
Antidepressants
Anticonvulsants
Anti-obesity Medications

Segment by Application


Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Binge Eating Disorder Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Binge Eating Disorder Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Binge Eating Disorder Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Binge Eating Disorder Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Binge Eating Disorder Drug introduction, etc. Binge Eating Disorder Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Binge Eating Disorder Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Binge Eating Disorder Drug Market Overview
1.1 Binge Eating Disorder Drug Product Overview
1.2 Binge Eating Disorder Drug Market Segment by Type
1.2.1 Antidepressants
1.2.2 Anticonvulsants
1.2.3 Anti-obesity Medications
1.3 Global Binge Eating Disorder Drug Market Size by Type
1.3.1 Global Binge Eating Disorder Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Binge Eating Disorder Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Binge Eating Disorder Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Binge Eating Disorder Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Binge Eating Disorder Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Binge Eating Disorder Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Binge Eating Disorder Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Binge Eating Disorder Drug Sales Breakdown by Type (2018-2024)
2 Global Binge Eating Disorder Drug Market Competition by Company
2.1 Global Top Players by Binge Eating Disorder Drug Sales (2018-2024)
2.2 Global Top Players by Binge Eating Disorder Drug Revenue (2018-2024)
2.3 Global Top Players by Binge Eating Disorder Drug Price (2018-2024)
2.4 Global Top Manufacturers Binge Eating Disorder Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Binge Eating Disorder Drug Market Competitive Situation and Trends
2.5.1 Binge Eating Disorder Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Binge Eating Disorder Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Binge Eating Disorder Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Binge Eating Disorder Drug Market
2.8 Key Manufacturers Binge Eating Disorder Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Binge Eating Disorder Drug Status and Outlook by Region
3.1 Global Binge Eating Disorder Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Binge Eating Disorder Drug Historic Market Size by Region
3.2.1 Global Binge Eating Disorder Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Binge Eating Disorder Drug Sales in Value by Region (2018-2024)
3.2.3 Global Binge Eating Disorder Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Binge Eating Disorder Drug Forecasted Market Size by Region
3.3.1 Global Binge Eating Disorder Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Binge Eating Disorder Drug Sales in Value by Region (2024-2034)
3.3.3 Global Binge Eating Disorder Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Binge Eating Disorder Drug by Application
4.1 Binge Eating Disorder Drug Market Segment by Application
4.1.1 Retail Pharmacies
4.1.2 Hospital Pharmacies
4.1.3 Online Pharmacies
4.2 Global Binge Eating Disorder Drug Market Size by Application
4.2.1 Global Binge Eating Disorder Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Binge Eating Disorder Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Binge Eating Disorder Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Binge Eating Disorder Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Binge Eating Disorder Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Binge Eating Disorder Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Binge Eating Disorder Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Binge Eating Disorder Drug Sales Breakdown by Application (2018-2024)
5 North America Binge Eating Disorder Drug by Country
5.1 North America Binge Eating Disorder Drug Historic Market Size by Country
5.1.1 North America Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Binge Eating Disorder Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Binge Eating Disorder Drug Sales in Value by Country (2018-2024)
5.2 North America Binge Eating Disorder Drug Forecasted Market Size by Country
5.2.1 North America Binge Eating Disorder Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Binge Eating Disorder Drug Sales in Value by Country (2024-2034)
6 Europe Binge Eating Disorder Drug by Country
6.1 Europe Binge Eating Disorder Drug Historic Market Size by Country
6.1.1 Europe Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Binge Eating Disorder Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Binge Eating Disorder Drug Sales in Value by Country (2018-2024)
6.2 Europe Binge Eating Disorder Drug Forecasted Market Size by Country
6.2.1 Europe Binge Eating Disorder Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Binge Eating Disorder Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Binge Eating Disorder Drug by Region
7.1 Asia-Pacific Binge Eating Disorder Drug Historic Market Size by Region
7.1.1 Asia-Pacific Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Binge Eating Disorder Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Binge Eating Disorder Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Binge Eating Disorder Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Binge Eating Disorder Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Binge Eating Disorder Drug Sales in Value by Region (2024-2034)
8 Latin America Binge Eating Disorder Drug by Country
8.1 Latin America Binge Eating Disorder Drug Historic Market Size by Country
8.1.1 Latin America Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Binge Eating Disorder Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Binge Eating Disorder Drug Sales in Value by Country (2018-2024)
8.2 Latin America Binge Eating Disorder Drug Forecasted Market Size by Country
8.2.1 Latin America Binge Eating Disorder Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Binge Eating Disorder Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Binge Eating Disorder Drug by Country
9.1 Middle East and Africa Binge Eating Disorder Drug Historic Market Size by Country
9.1.1 Middle East and Africa Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Binge Eating Disorder Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Binge Eating Disorder Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Binge Eating Disorder Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Binge Eating Disorder Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Binge Eating Disorder Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Roche
10.1.1 Roche Company Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Roche Binge Eating Disorder Drug Products Offered
10.1.5 Roche Recent Development
10.2 Chronos Therapeutics
10.2.1 Chronos Therapeutics Company Information
10.2.2 Chronos Therapeutics Introduction and Business Overview
10.2.3 Chronos Therapeutics Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Chronos Therapeutics Binge Eating Disorder Drug Products Offered
10.2.5 Chronos Therapeutics Recent Development
10.3 Heptares
10.3.1 Heptares Company Information
10.3.2 Heptares Introduction and Business Overview
10.3.3 Heptares Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Heptares Binge Eating Disorder Drug Products Offered
10.3.5 Heptares Recent Development
10.4 Novo Nordisk
10.4.1 Novo Nordisk Company Information
10.4.2 Novo Nordisk Introduction and Business Overview
10.4.3 Novo Nordisk Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Novo Nordisk Binge Eating Disorder Drug Products Offered
10.4.5 Novo Nordisk Recent Development
10.5 Omeros Corp
10.5.1 Omeros Corp Company Information
10.5.2 Omeros Corp Introduction and Business Overview
10.5.3 Omeros Corp Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Omeros Corp Binge Eating Disorder Drug Products Offered
10.5.5 Omeros Corp Recent Development
10.6 Sunovion Pharmaceuticals
10.6.1 Sunovion Pharmaceuticals Company Information
10.6.2 Sunovion Pharmaceuticals Introduction and Business Overview
10.6.3 Sunovion Pharmaceuticals Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Sunovion Pharmaceuticals Binge Eating Disorder Drug Products Offered
10.6.5 Sunovion Pharmaceuticals Recent Development
10.7 Opiant Pharmaceuticals
10.7.1 Opiant Pharmaceuticals Company Information
10.7.2 Opiant Pharmaceuticals Introduction and Business Overview
10.7.3 Opiant Pharmaceuticals Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Opiant Pharmaceuticals Binge Eating Disorder Drug Products Offered
10.7.5 Opiant Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Binge Eating Disorder Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Binge Eating Disorder Drug Industrial Chain Analysis
11.4 Binge Eating Disorder Drug Market Dynamics
11.4.1 Binge Eating Disorder Drug Industry Trends
11.4.2 Binge Eating Disorder Drug Market Drivers
11.4.3 Binge Eating Disorder Drug Market Challenges
11.4.4 Binge Eating Disorder Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Binge Eating Disorder Drug Distributors
12.3 Binge Eating Disorder Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Antidepressants
Table 2. Major Company of Anticonvulsants
Table 3. Major Company of Anti-obesity Medications
Table 4. Global Binge Eating Disorder Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Binge Eating Disorder Drug Sales by Type (2018-2024) & (K Units)
Table 6. Global Binge Eating Disorder Drug Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Binge Eating Disorder Drug Sales by Type (2018-2024) & (US& Million)
Table 8. Global Binge Eating Disorder Drug Market Share in Value by Type (2018-2024)
Table 9. Global Binge Eating Disorder Drug Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Binge Eating Disorder Drug Sales by Type (2024-2034) & (K Units)
Table 11. Global Binge Eating Disorder Drug Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Binge Eating Disorder Drug Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Binge Eating Disorder Drug Sales Market Share in Value by Type (2024-2034)
Table 14. Global Binge Eating Disorder Drug Price by Type (2024-2034) & (USD/Unit)
Table 15. North America Binge Eating Disorder Drug Sales by Type (2018-2024) & (K Units)
Table 16. North America Binge Eating Disorder Drug Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Binge Eating Disorder Drug Sales (K Units) by Type (2018-2024)
Table 18. Europe Binge Eating Disorder Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Binge Eating Disorder Drug Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Binge Eating Disorder Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Binge Eating Disorder Drug Sales (K Units) by Type (2018-2024)
Table 22. Latin America Binge Eating Disorder Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Binge Eating Disorder Drug Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Binge Eating Disorder Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Binge Eating Disorder Drug Sales by Company (2018-2024) & (K Units)
Table 26. Global Binge Eating Disorder Drug Sales Share by Company (2018-2024)
Table 27. Global Binge Eating Disorder Drug Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Binge Eating Disorder Drug Revenue Share by Company (2018-2024)
Table 29. Global Market Binge Eating Disorder Drug Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Binge Eating Disorder Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Binge Eating Disorder Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Binge Eating Disorder Drug as of 2022)
Table 33. Date of Key Manufacturers Enter into Binge Eating Disorder Drug Market
Table 34. Key Manufacturers Binge Eating Disorder Drug Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Binge Eating Disorder Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Binge Eating Disorder Drug Sales by Region (2018-2024) & (K Units)
Table 38. Global Binge Eating Disorder Drug Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Binge Eating Disorder Drug Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Binge Eating Disorder Drug Sales Market Share in Value by Region (2018-2024)
Table 41. Global Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Binge Eating Disorder Drug Sales by Region (2024-2034) & (K Units)
Table 43. Global Binge Eating Disorder Drug Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Binge Eating Disorder Drug Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Binge Eating Disorder Drug Sales Market Share in Value by Region (2024-2034)
Table 46. Global Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global Binge Eating Disorder Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Binge Eating Disorder Drug Sales by Application (2018-2024) & (K Units)
Table 49. Global Binge Eating Disorder Drug Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Binge Eating Disorder Drug Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Binge Eating Disorder Drug Sales Market Share in Value by Application (2018-2024)
Table 52. Global Binge Eating Disorder Drug Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Binge Eating Disorder Drug Sales by Application (2024-2034) & (K Units)
Table 54. Global Binge Eating Disorder Drug Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Binge Eating Disorder Drug Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Binge Eating Disorder Drug Sales Market Share in Value by Application (2024-2034)
Table 57. Global Binge Eating Disorder Drug Price by Application (2024-2034) & (USD/Unit)
Table 58. North America Binge Eating Disorder Drug Sales by Application (2018-2024) (K Units)
Table 59. North America Binge Eating Disorder Drug Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Binge Eating Disorder Drug Sales by Application (2018-2024) (K Units)
Table 61. Europe Binge Eating Disorder Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Binge Eating Disorder Drug Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Binge Eating Disorder Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Binge Eating Disorder Drug Sales by Application (2018-2024) (K Units)
Table 65. Latin America Binge Eating Disorder Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Binge Eating Disorder Drug Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Binge Eating Disorder Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Binge Eating Disorder Drug Sales by Country (2018-2024) & (K Units)
Table 69. North America Binge Eating Disorder Drug Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Binge Eating Disorder Drug Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Binge Eating Disorder Drug Sales Market Share in Value by Country (2018-2024)
Table 72. North America Binge Eating Disorder Drug Sales by Country (2024-2034) & (K Units)
Table 73. North America Binge Eating Disorder Drug Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Binge Eating Disorder Drug Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Binge Eating Disorder Drug Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Binge Eating Disorder Drug Sales by Country (2018-2024) & (K Units)
Table 77. Europe Binge Eating Disorder Drug Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Binge Eating Disorder Drug Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Binge Eating Disorder Drug Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Binge Eating Disorder Drug Sales by Country (2024-2034) & (K Units)
Table 81. Europe Binge Eating Disorder Drug Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Binge Eating Disorder Drug Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Binge Eating Disorder Drug Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Binge Eating Disorder Drug Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Binge Eating Disorder Drug Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Binge Eating Disorder Drug Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Binge Eating Disorder Drug Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Binge Eating Disorder Drug Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Binge Eating Disorder Drug Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Binge Eating Disorder Drug Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Binge Eating Disorder Drug Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Binge Eating Disorder Drug Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Binge Eating Disorder Drug Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Binge Eating Disorder Drug Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Binge Eating Disorder Drug Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Binge Eating Disorder Drug Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Binge Eating Disorder Drug Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Binge Eating Disorder Drug Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Binge Eating Disorder Drug Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Binge Eating Disorder Drug Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Binge Eating Disorder Drug Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Binge Eating Disorder Drug Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Binge Eating Disorder Drug Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Binge Eating Disorder Drug Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Binge Eating Disorder Drug Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Binge Eating Disorder Drug Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Binge Eating Disorder Drug Sales Market Share in Value by Country (2024-2034)
Table 108. Roche Company Information
Table 109. Roche Introduction and Business Overview
Table 110. Roche Binge Eating Disorder Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Roche Binge Eating Disorder Drug Product
Table 112. Roche Recent Development
Table 113. Chronos Therapeutics Company Information
Table 114. Chronos Therapeutics Introduction and Business Overview
Table 115. Chronos Therapeutics Binge Eating Disorder Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Chronos Therapeutics Binge Eating Disorder Drug Product
Table 117. Chronos Therapeutics Recent Development
Table 118. Heptares Company Information
Table 119. Heptares Introduction and Business Overview
Table 120. Heptares Binge Eating Disorder Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Heptares Binge Eating Disorder Drug Product
Table 122. Heptares Recent Development
Table 123. Novo Nordisk Company Information
Table 124. Novo Nordisk Introduction and Business Overview
Table 125. Novo Nordisk Binge Eating Disorder Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Novo Nordisk Binge Eating Disorder Drug Product
Table 127. Novo Nordisk Recent Development
Table 128. Omeros Corp Company Information
Table 129. Omeros Corp Introduction and Business Overview
Table 130. Omeros Corp Binge Eating Disorder Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Omeros Corp Binge Eating Disorder Drug Product
Table 132. Omeros Corp Recent Development
Table 133. Sunovion Pharmaceuticals Company Information
Table 134. Sunovion Pharmaceuticals Introduction and Business Overview
Table 135. Sunovion Pharmaceuticals Binge Eating Disorder Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Sunovion Pharmaceuticals Binge Eating Disorder Drug Product
Table 137. Sunovion Pharmaceuticals Recent Development
Table 138. Opiant Pharmaceuticals Company Information
Table 139. Opiant Pharmaceuticals Introduction and Business Overview
Table 140. Opiant Pharmaceuticals Binge Eating Disorder Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Opiant Pharmaceuticals Binge Eating Disorder Drug Product
Table 142. Opiant Pharmaceuticals Recent Development
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Binge Eating Disorder Drug Market Trends
Table 146. Binge Eating Disorder Drug Market Drivers
Table 147. Binge Eating Disorder Drug Market Challenges
Table 148. Binge Eating Disorder Drug Market Restraints
Table 149. Binge Eating Disorder Drug Distributors List
Table 150. Binge Eating Disorder Drug Downstream Customers
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Binge Eating Disorder Drug Product Picture
Figure 2. Global Binge Eating Disorder Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Binge Eating Disorder Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Binge Eating Disorder Drug Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Antidepressants
Figure 6. Global Antidepressants Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Anticonvulsants
Figure 8. Global Anticonvulsants Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Anti-obesity Medications
Figure 10. Global Anti-obesity Medications Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Binge Eating Disorder Drug Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Binge Eating Disorder Drug Sales Market Share by Type in 2022 & 2034
Figure 13. North America Binge Eating Disorder Drug Sales Market Share in Volume by Type in 2022
Figure 14. North America Binge Eating Disorder Drug Sales Market Share in Value by Type in 2022
Figure 15. Europe Binge Eating Disorder Drug Sales Market Share in Volume by Type in 2022
Figure 16. Europe Binge Eating Disorder Drug Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Binge Eating Disorder Drug Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Binge Eating Disorder Drug Sales Market Share in Value by Type in 2022
Figure 19. Latin America Binge Eating Disorder Drug Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Binge Eating Disorder Drug Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Binge Eating Disorder Drug Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Binge Eating Disorder Drug Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Binge Eating Disorder Drug Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Binge Eating Disorder Drug Revenue in 2022
Figure 25. Binge Eating Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Retail Pharmacies
Figure 27. Global Retail Pharmacies Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Hospital Pharmacies
Figure 29. Global Hospital Pharmacies Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Online Pharmacies
Figure 31. Global Online Pharmacies Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Global Binge Eating Disorder Drug Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Binge Eating Disorder Drug Sales Market Share by Application in 2022 & 2034
Figure 34. North America Binge Eating Disorder Drug Sales Market Share in Volume by Application in 2022
Figure 35. North America Binge Eating Disorder Drug Sales Market Share in Value by Application in 2022
Figure 36. Europe Binge Eating Disorder Drug Sales Market Share in Volume by Application in 2022
Figure 37. Europe Binge Eating Disorder Drug Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Binge Eating Disorder Drug Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Binge Eating Disorder Drug Sales Market Share in Value by Application in 2022
Figure 40. Latin America Binge Eating Disorder Drug Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Binge Eating Disorder Drug Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Binge Eating Disorder Drug Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Binge Eating Disorder Drug Manufacturing Cost Structure
Figure 45. Binge Eating Disorder Drug Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries